PB2122: A PHASE 1/2 MULTI-CENTER, DOSE-FINDING STUDY INVESTIGATING THE SAFETY, TOLERABILITY, PK AND EFFICACY OF ZN-D5, A NOVEL BCL-2 INHIBITOR, IN PATIENTS WITH RELAPSED/REFRACTORY AL AMYLOIDOSIS

ABSTRACT:

SUBMITTER: Kastritis E 

PROVIDER: S-EPMC10429019 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature